Cryopreservation of haptenized tumor cells
OwnerDavid Berd, Lorne Erdile +1inventors
InventorsDavid Berd, Lorne Erdile, Margalit Mokyr
Life of this patent
Estimating the term…
Loading patent…
OwnerDavid Berd, Lorne Erdile +1inventors
InventorsDavid Berd, Lorne Erdile, Margalit Mokyr
Estimating the term…
A method of preserving haptenized tumor cells is described. The method employs a freezing medium containing an effective amount of sucrose and human serum albumin in an isotonic buffered saline solution. Cryogenically preserving haptenized cells in such a medium has been found to maintain the integrity of the tumor cells during storage. The haptenized tumor cells also retain cell-associated antigens and haptens, and are as immunogenic, i.e., capable of inducing immunotherapeutic response, as fresh vaccine in a mouse model of metastatic disease. In a specific embodiment, haptenized cells are exposed to a solution of 8% sucrose, 10% human serum albumin in Hank's buffered solution, and then frozen to −80° C. overnight and then stored in a liquid nitrogen freezer. Methods of storing haptenized tumor cells and compositions are also provided.
A method of preserving haptenized tumor cells, which method comprises:
A method of storage for haptenized tumor cells for use in a vaccine, which method comprises storing a haptenized tumor cells and a freezing medium composition at a temperature below the freezing temperature for at least 3 months.
A composition comprising haptenized tumor cells for use in a vaccine and a freezing medium, wherein the freezing medium comprises sucrose, human serum albumin and an isotonic buffered saline solution.
Dependencies are inferred from the claim text.